Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange

Documenti analoghi

• Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange
  di: Florian Tupin, et al.
  Pubblicazione: (2026)
• Further thoughts on a lower fibrinogen threshold prior to therapeutic plasma exchange
  di: Kamran Urgun, et al.
  Pubblicazione: (2025)
• Exploring the experiences of hemochromatosis (HHC) patients who undergo therapeutic venesection at a blood collection agency
  di: Rachel Thorpe, et al.
  Pubblicazione: (2025)
• Exchange transfusion and pre‐filter apheresis dilution for hyperviscosity syndrome refractory to conventional therapeutic plasma exchange in a patient with IgA multiple myeloma
  di: Anthony Valin‐Thorburn, et al.
  Pubblicazione: (2025)
• A lower fibrinogen threshold does not lead to increased bleeding risk in patients receiving therapeutic plasma exchange: A prospective single‐center analysis
  di: Amelework Wodajo, et al.
  Pubblicazione: (2024)